logo
Francis still requires therapy, Vatican says, as pope looks ahead to 2028

Francis still requires therapy, Vatican says, as pope looks ahead to 2028

Yahoo15-03-2025

Pope Francis is improving but still requires various in-hospital therapies, the Vatican said Saturday, even as it revealed the 88-year-old pontiff had laid plans to extend his years-long Synod process into 2028.
The Argentine pope on Friday marked one month in Rome's Gemelli hospital, where doctors for days have said his condition is stable and slowly improving after a critical period marked by breathing crises that risked his life.
But on Saturday, the Vatican cut short any speculation he could be released imminently, cautioning that, despite the progress, he still required therapies to be administered within a hospital environment.
"The clinical conditions of the Holy Father have remained stable, confirming the progress shown in the last week," the Vatican said in an evening bulletin on his health.
"The Holy Father still requires hospital medical therapy, motor and respiratory physiotherapy; these therapies, at present, are showing further, gradual improvements," it added.
The Vatican has given no indication as to when Francis could be released from the hospital's special papal suite on the 10th floor.
But in a sign that Francis continues to work to cement his legacy for reform of the Church, the Vatican also said Saturday he had approved from his hospital bed a new plan related to the Synod, a years-long global consultation that he has shepherded since 2021.
The Synod, which focused on pressing issues affecting the future of the Catholic Church, ended in October, with the pope yet to reveal whether he will incorporate its findings into a papal document known as an apostolic exhortation.
The extension announced Saturday calls for a three-year consultation and evaluation period leading up to a new post-Synod assembly in 2028.
"On 11 March, the Holy Father definitively approved the start of a process of accompaniment and evaluation of the implementation phase by the General Secretariat of the Synod," the Vatican said.
The Synod was the first time the Vatican waded into so many contentious, contemporary social issues so openly, from LGBTQ Catholics to whether women should be ordained as deacons.
The Vatican said the three-year consultation period would involve dioceses and episcopal conferences, as well as lay associations and other parties -- including women -- who have contributed to the Synod process until now.
"It is of fundamental importance to ensure that the implementation phase serves as an opportunity to re-engage the people who have contributed and to present the fruits gathered from listening to all the Churches," said the Vatican.
Maltese Cardinal Mario Grech announced the start of the implementation phase in a letter sent Saturday to bishops around the world.
- Heavier mail bags -
Meanwhile, even as he improves, the pope is still receiving "thousands" of get-well letters a day from around the world, Italy's postal service said.
Well-wishers have been flooding the city's postal service with letters "from the time of his hospitalisation until today," the postal service said in a statement.
The "surge" in correspondence was being felt at the Fiumicino postal sorting centre, with "up to 150 kilograms more mail per day," said the unit's head, Antonello Chidichimo.
In a bit of self-promotion, the postal service said it was playing a "fundamental role in ensuring that every message of support and prayer reaches its destination".
On the anniversary of Francis's 12 years as pope Friday, his favourite football team -- Buenos Aires' San Lorenzo -- posted a video message of support, with other messages arriving from Brazilian footballer Neymar and Italy's former player Ciro Ferrara.
The Argentine pontiff has previously thanked well-wishers for their letters and prayers, noting their "affection and closeness".
In February, ten days after Francis was hospitalised, the Vatican published a message written by him in which he cited the "many messages of affection".
"I have been particularly struck by the letters and drawings from children," wrote Francis.
ams/gv

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Baby swabs and nasal swabs recalled for possible fungus in swab parts
Baby swabs and nasal swabs recalled for possible fungus in swab parts

Miami Herald

time9 hours ago

  • Miami Herald

Baby swabs and nasal swabs recalled for possible fungus in swab parts

Swabs for teething babies and adult noses have been recalled because they might have a microbial contamination 'identified as fungi in cotton swab components.' That's what manufacturer Church & Dwight said in its notice announcing the recall of Orajel Baby Teething Swabs, Zicam Cold Remedy Nasal Swabs and Zicam Nasal AllClear Swabs from stores across the United States, including Puerto Rico. The lots and expiration dates involved? All. READ MORE: Recalled UTI drug could have deadly microbial contamination What can contaminated swabs do? Swabs with a microbial contamination can cause 'serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injurie,' the recall notice states. 'The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions.' Exactly which Orajel and Zicam swabs are recalled? ▪ Zicam Cold Remedy Nasal Swabs carry UPC No. 732216301205. ▪ Zicam Nasal AllClear Swabs, which were discontinued in December, carry UPC No. 732216301656. ▪ Orajel baby swabs carry UPC No. 310310400002. What should you do now? If you have the swabs, throw them in the trash or, for a refund, reach out go Church & Dwight either online or by calling 800-981-4710. Questions can be directed to that phone number, 9 a.m. to 5 p.m., Monday through Friday. If you think you or your baby is having a medical issue caused by these swabs, go see a medical professional. Then, notify the FDA's MedWatch Adverse Event Program, either by filling out a form online or by requesting a reporting form at 800-332-1088. Then, third, call Church & Dwight.

Beyond MAHA: Defeating obesity requires a new strategy
Beyond MAHA: Defeating obesity requires a new strategy

The Hill

time11 hours ago

  • The Hill

Beyond MAHA: Defeating obesity requires a new strategy

Obesity is a major health problem facing our country. According to the CDC, more than 40 percent of the U.S. population is obese, defined as having a body-mass index above 30. As astounding at that number is, it is perhaps even more surprising that nearly 20 percent of children in the U.S. are obese. Obesity leads to significant health challenges, including diabetes, stroke, cardiovascular disease and liver disease. It is clear that as a nation we must face this crisis on multiple fronts. Diet and exercise certainly help, and it's critical to ensure that people of all socioeconomic backgrounds have access to healthy foods (free of preservatives, unnecessary dyes, high fructose corn syrups etc.) and are educated in making healthy lifestyle choices. The MAHA or 'Make America Healthy Again' movement has highlighted this as one of its key objectives, and if it is successful, we should see an impact on obesity — especially in children, where diet and exercise have a huge impact on weight-related health outcomes. Obesity in adults, however, is often more challenging. Many adults with obesity struggle to lose weight, despite considerable efforts to modify their lifestyle through diet and exercise. This is because our metabolism changes as we age, and many adults who are overweight develop metabolic dysfunction or 'metabolic syndrome,' which then further perpetuates weight gain and exacerbates the situation. It has become clear in recent years that many people struggling with obesity require medical intervention – not just lifestyle intervention – and that prescriptions can substantially improve weight loss. The explosion in use of GLP-1 agonists, such as Wegovy and Zepbound, over the last two years has underscored the need for medical intervention in obese and overweight patients. Currently, about 6 percent of the U.S. population, or 15 million people, are on GLP-1 weight loss treatments, and the numbers are only expected to increase. However, while most patients lose 10 percent to 25 percent of their body weight while on a GLP-1, they do not maintain GLP-1 treatment in the long-term, with approximately 80 percent of patients discontinuing treatment within 1 year. Gastrointestinal side effects, injectable administration, and high cost have prevented long-term use of GLP-1's for weight maintenance. And unfortunately, most patients gain back all the weight after stopping the medication. Healthcare professionals and the pharmaceutical industry now recognize that obesity — like most other medical conditions — requires an 'arsenal' of treatments, rather than a one-size-fits-all approach. Post-GLP-1 weight maintenance is now widely recognized as an emerging unmet need. And patients who are not candidates for or cannot tolerate GLP-1s require alternatives. Diet and lifestyle modifications are important alongside prescription medications in fighting obesity. If we are going to be successful in overcoming this major health crisis, we need to ensure that both the pharmaceutical industry and groups like MAHA work hand in hand. Both treatment and prevention are critical in order to regain control of our nation's health. Dr. Shoshana Shendelman, Ph.D. is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs and therapeutics for rare and underserved diseases. Currently she is Vice Chair of the Advisory Board of Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.

Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears
Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears

Epoch Times

timea day ago

  • Epoch Times

Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears

New Jersey-based Church & Dwight Co., Inc. is recalling three nasal and baby teething swab products due to potential fungal contamination in the cotton swab components, the company said in a June 6 The recall is applicable to three products: Zicam Cold Remedy Nasal Swabs designed to tackle the common cold, Zicam Nasal AllClear Swabs used for cleansing, and Orajel Baby Teething Swabs aimed at soothing teething discomfort among toddlers and infants.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store